[HTML][HTML] The successful treatment of severe aplastic anemia with autologous cord blood transplantation
SM Fruchtman, A Hurlet, R Dracker, L Isola… - Biology of Blood and …, 2004 - Elsevier
SM Fruchtman, A Hurlet, R Dracker, L Isola, B Goldman, BL Schneider, S Emre
Biology of Blood and Marrow Transplantation, 2004•ElsevierCord blood transplantation has been used extensively in the allogeneic setting for acquired
and genetic disorders of hematopoiesis. There is less experience in the utility of autologous
cord blood transplantation, and there is great controversy about the role of autologous cord
blood collection and storage. We report on the successful use of autologous cord blood
transplantation for the treatment of severe aplastic anemia following fulminant hepatic failure
and living related liver transplantation.
and genetic disorders of hematopoiesis. There is less experience in the utility of autologous
cord blood transplantation, and there is great controversy about the role of autologous cord
blood collection and storage. We report on the successful use of autologous cord blood
transplantation for the treatment of severe aplastic anemia following fulminant hepatic failure
and living related liver transplantation.
Cord blood transplantation has been used extensively in the allogeneic setting for acquired and genetic disorders of hematopoiesis. There is less experience in the utility of autologous cord blood transplantation, and there is great controversy about the role of autologous cord blood collection and storage. We report on the successful use of autologous cord blood transplantation for the treatment of severe aplastic anemia following fulminant hepatic failure and living related liver transplantation.
Elsevier
